Tzu-Hao Chang Selected Research

Collagen Type XI

12/2021	miR-335 Restrains the Aggressive Phenotypes of Ovarian Cancer Cells by Inhibiting COL11A1.
1/2021	COL11A1 activates cancer-associated fibroblasts by modulating TGF-β3 through the NF-κB/IGFBP2 axis in ovarian cancer cells.
12/2017	Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-κB-mediated IKKβ expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tzu-Hao Chang Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 01/2012
4	Chronic Renal Insufficiency 11/2022 - 01/2014
4	Carcinogenesis 01/2020 - 01/2015
4	Mitral Valve Insufficiency (Mitral Regurgitation) 12/2018 - 05/2015
3	Carcinoma (Carcinomatosis) 01/2022 - 11/2018
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2014
3	Fibrosis (Cirrhosis) 01/2022 - 05/2015
3	Ovarian Epithelial Carcinoma 12/2021 - 01/2021
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2015
2	Infections 01/2022 - 12/2017
2	Disease Progression 01/2022 - 06/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2015
2	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 03/2019
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
2	Ischemic Stroke 01/2021 - 01/2015
2	Lymphatic Metastasis 01/2019 - 03/2018
2	Papillomavirus Infections 11/2018 - 01/2018
2	Heart Failure 01/2018 - 11/2016
2	Aortic Valve Disease 01/2018 - 01/2016
2	Stroke (Strokes) 01/2015 - 01/2014
1	Lactic Acidosis 11/2022
1	Osteoporosis 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Arteriovenous Fistula 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Adenocarcinoma 01/2022
1	Thrombosis (Thrombus) 12/2021
1	Prostatic Neoplasms (Prostate Cancer) 05/2021
1	COVID-19 01/2021
1	Hemorrhage 01/2021
1	Colonic Neoplasms (Colon Cancer) 06/2020
1	Rhinosinusitis 11/2019
1	Glioma (Gliomas) 03/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Endometrial Neoplasms (Endometrial Cancer) 01/2019
1	Genital Diseases 11/2018
1	Virus Diseases (Viral Diseases) 11/2018
1	Mouth Neoplasms (Oral Cancer) 03/2018

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
6	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2015
6	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2015
5	Pharmaceutical PreparationsIBA 11/2022 - 01/2012
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2015
3	Biological ProductsIBA 01/2022 - 01/2014
3	Messenger RNA (mRNA)IBA 01/2022 - 11/2016
3	Collagen Type XIIBA 12/2021 - 12/2017
2	EnzymesIBA 01/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 06/2020
2	InterleukinsIBA 06/2020 - 01/2020
2	LipidsIBA 01/2019 - 12/2018
2	Angiotensin IIIBA 01/2018 - 05/2015
1	Metformin (Glucophage)FDA LinkGeneric 11/2022
1	Denosumab FDA Link 01/2022
1	Raloxifene Hydrochloride (Evista)FDA Link 01/2022
1	Teriparatide (Parathar)FDA Link 01/2022
1	Diphosphonates (Bisphosphonates)IBA 01/2022
1	LectinsIBA 01/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2022
1	PlatinumIBA 01/2022
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 01/2022
1	LaxativesIBA 01/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2022
1	Estrone FDA Link 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	VaccinesIBA 01/2022
1	Galectin 1 (LGALS1)IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Circular RNAIBA 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	SphingolipidsIBA 12/2021
1	Temozolomide (Temodar)FDA LinkGeneric 10/2021
1	Moclobemide (Arima)IBA 01/2021
1	CollagenIBA 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021
1	ribociclibIBA 01/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	Collagen Type VIIBA 01/2021
1	Leucine (L-Leucine)FDA Link 06/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2020
1	Adenosine Triphosphate (ATP)IBA 06/2020
1	CateninsIBA 06/2020
1	Fluorouracil (Carac)FDA LinkGeneric 06/2020
1	Janus KinasesIBA 06/2020
1	ErbB Receptors (EGF Receptor)IBA 06/2020
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2019
1	Liver X ReceptorsIBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	CytokinesIBA 01/2019
1	AntagomirsIBA 01/2018
1	TeaIBA 12/2017

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2014
3	Drug Therapy (Chemotherapy) 12/2021 - 01/2015
1	Adjuvant Chemotherapy 01/2022
1	Renal Dialysis (Hemodialysis) 01/2022
1	Intravenous Injections 01/2021
1	Endoscopes 11/2019
1	Bariatric Surgery 01/2019